Brief: Rigel Reports First Quarter 2023 Financial Results And Provides Business Update
02/05/2023 22:18
May 2 (Reuters) - Rigel Pharmaceuticals Inc RIGL.O :
* RIGEL REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
* RIGEL PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.08
* RIGEL PHARMACEUTICALS INC - AS OF MARCH 31, CASH, CASH
EQUIVALENTS & SHORT-TERM INVESTMENTS OF $58.7 MILLION, COMPARED
TO $58.2 MILLION AS OF DEC 31, 2022
Source text for Eikon: ID:nPnHfhTQa
Further company coverage: RIGL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rigel Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Rigel Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rigel Pharmaceuticals Q2 revenue rises on strong product demand
Brief: Rigel Pharmaceuticals - Appoints Alison L. Hannah As Executive Vice President And Chief Medical Officer Effective July 1, 2026 - SEC Filing
Brief: Rigel Announces Closing Of Licensing Agreement For Veppanu (Vepdegestrant)